Mixed adenoneuroendocrine carcinoma of the ampulla: two case reports

World J Gastroenterol. 2015 Feb 21;21(7):2254-9. doi: 10.3748/wjg.v21.i7.2254.

Abstract

Mixed adenoneuroendocrine carcinoma (MANEC) is a malignant tumor with adenocarcinoma and neuroendocrine components, with ≥30% of each component required. MANEC of the ampulla is rare. To the best of our knowledge, only 15 cases of MANEC of the ampulla have been reported in the English-language literature. Here, we report two cases of MANEC of the ampulla in two women aged 43 and 60 years, which was confirmed by histology after pancreaticoduodenectomy. These tumors contained neuroendocrine and adenocarcinoma components. The neuroendocrine components were positive for chromogranin A (CgA), synaptophysin (Syn) and CD56 by immunostaining. The adenocarcinoma components were negative for CgA, Syn and CD56. Both cases were T3N0M0 (Stage IIIA). They survived for 15 and 20 mo after surgery, respectively. A brief discussion about the histopathological features, clinical behavior and treatment of MANEC of ampulla, and review of the relevant literature are presented.

Keywords: Ampulla; Composite carcinoma; Immunohistochemical; Mixed adenoneuroendocrine carcinoma; Neuroendocrine tumor.

Publication types

  • Case Reports
  • Review

MeSH terms

  • Adenocarcinoma / chemistry
  • Adenocarcinoma / pathology*
  • Adenocarcinoma / surgery
  • Adult
  • Ampulla of Vater / chemistry
  • Ampulla of Vater / pathology*
  • Ampulla of Vater / surgery
  • Biomarkers, Tumor / analysis
  • Biopsy
  • Cholangiopancreatography, Endoscopic Retrograde
  • Common Bile Duct Neoplasms / chemistry
  • Common Bile Duct Neoplasms / pathology*
  • Common Bile Duct Neoplasms / surgery
  • Female
  • Humans
  • Immunohistochemistry
  • Middle Aged
  • Neoplasms, Complex and Mixed / chemistry
  • Neoplasms, Complex and Mixed / pathology*
  • Neoplasms, Complex and Mixed / surgery
  • Neuroendocrine Tumors / chemistry
  • Neuroendocrine Tumors / pathology*
  • Neuroendocrine Tumors / surgery
  • Pancreaticoduodenectomy
  • Treatment Outcome

Substances

  • Biomarkers, Tumor